Association of common susceptibility variants of pancreatic cancer in higher-risk patients: A PACGENE study

Erica J. Childs, Kari G. Chaffee, Steven Gallinger, Sapna Syngal, Ann G. Schwartz, Michele L. Cote, Melissa L. Bondy, Ralph H Hruban, Stephen J. Chanock, Robert N. Hoover, Charles S. Fuchs, David N. Rider, Laufey T. Amundadottir, Rachael Stolzenberg-Solomon, Brian M. Wolpin, Harvey A. Risch, Michael S Goggins, Gloria M. Petersen, Alison Klein

Research output: Contribution to journalArticle

Abstract

Individuals from pancreatic cancer families are at increased risk, not only of pancreatic cancer, but also of melanoma, breast, ovarian, and colon cancers. While some of the increased risk may be due to mutations in high-penetrance genes (i.e., BRCA2, PALB2, ATM, p16/CDKN2A or DNA mismatch repair genes), common genetic variants may also be involved. In a high-risk population of cases with either a family history of pancreatic cancer or early-onset pancreatic cancer (diagnosis before the age of 50 years), we examined the role of genetic variants previously associated with risk of pancreatic, breast, ovarian, or prostate cancer. We genotyped 985 cases (79 earlyonset cases, 906 cases with a family history of pancreatic cancer) and 877 controls for 215,389 SNPs using the iSelect Collaborative Oncological Gene-Environment Study (iCOGS) array with custom content. Logistic regression was performed using a log-linear additive model. We replicated several previously reported pancreatic cancer susceptibility loci, including recently identified variants on 2p13.3 and 7p13 (2p13.3, rs1486134: OR = 1.36; 95% CI, 1.13-1.63; P = 9.29 × 10-4; 7p13, rs17688601: OR = 0.76; 95%CI, 0.63-0.93; P=6.59 × 103). For the replicated loci, the magnitude of association observed in these high-risk patients was similar to that observed in studies of unselected patients. In addition to the established pancreatic cancer loci, we also found suggestive evidence of association (P <5 × 105) to pancreatic cancer for SNPs atHDAC9(7p21.1) and COL6A2 (21q22.3). Even in high-risk populations, common variants influence pancreatic cancer susceptibility.

Original languageEnglish (US)
Pages (from-to)1185-1191
Number of pages7
JournalCancer Epidemiology Biomarkers and Prevention
Volume25
Issue number7
DOIs
StatePublished - Jul 1 2016

ASJC Scopus subject areas

  • Epidemiology
  • Oncology

Fingerprint Dive into the research topics of 'Association of common susceptibility variants of pancreatic cancer in higher-risk patients: A PACGENE study'. Together they form a unique fingerprint.

  • Cite this

    Childs, E. J., Chaffee, K. G., Gallinger, S., Syngal, S., Schwartz, A. G., Cote, M. L., Bondy, M. L., Hruban, R. H., Chanock, S. J., Hoover, R. N., Fuchs, C. S., Rider, D. N., Amundadottir, L. T., Stolzenberg-Solomon, R., Wolpin, B. M., Risch, H. A., Goggins, M. S., Petersen, G. M., & Klein, A. (2016). Association of common susceptibility variants of pancreatic cancer in higher-risk patients: A PACGENE study. Cancer Epidemiology Biomarkers and Prevention, 25(7), 1185-1191. https://doi.org/10.1158/1055-9965.EPI-15-1217